Pfizer, Inc. (PFE)
44.06 -0.63%
Feb 04 close; Powered by Koyfin
Pros
Revenue growth higher than the industry and sector averages
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/B ratio low relative to industry peers
Forward P/S ratio low relative to industry peers
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
High short interest
Pros
- PFE quarterly revenue growth was 46.80%, higher than the industry and sector average revenue growth (12.60% and 5.67%, respectively). See PFE revenue growth chart.
- PFE profitability is improving. The YoY profit margin change was 26.89 percentage points. See PFE profitability chart.
- PFE forward dividend yield is 3.51%, higher than the industry (2.18%) and sector (0.20%) forward dividend yields. See PFE forward dividend chart.
- PFE Price/Book ratio is 3.86, which is low compared to its industry peers’ P/B ratios. See PFE forward Price/Book ratio chart.
- PFE Price/Sales ratio is 2.43, which is low compared to its industry peers’ P/S ratios. See PFE forward Price/Sales ratio chart.
- PFE PEG ratio (P/E adjusted for growth) is 0.01, which is low compared to its industry peers’ PEG ratios. See PFE PEG chart.
- PFE average analyst rating is Buy. See PFE analyst rating chart.
- PFE average analyst price target ($55.88) is above its current price ($43.97). See PFE price target chart.
Cons
- PFE short interest (days to cover the shorts) ratio is 3.19. The stock garners more short interest than the average industry, sector or S&P 500 stock. See PFE short interest ratio chart.